Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
September 07, 2016Stephen T. Oh, MD, PhD: Interplay of Somatic and Germline Variants in MPNWebcast: 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes28 minPlay
September 07, 2016Jason R. Gotlib, MD, MS: Biology and Therapy of Eosinophilic MPNsWebcast: 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes28 minPlay
September 07, 2016Mark Heaney, MD, PhD: The WHO Updated Diagnostic Criteria for ET, PV and MFWebcast: 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes22 minPlay
September 07, 2016Michael Kroll, MD: Splanchnic Vein Thrombosis and MPN: Diagnosis and TherapyWebcast: 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes23 minPlay
September 07, 2016Richard T. Silver, MD: Update on Long-acting Interferons for MPNWebcast: 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes22 minPlay
September 07, 2016Ellen Ritchie, MD: JAK Inhibitors for ET and PV: What Have We Learned So FarWebcast: 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes23 minPlay
September 07, 2016Amy E. DeZern, MD, MHS: An Approach to Diagnosis and Staging of MDS: From Morphology to GeneticsWebcast: 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes20 minPlay
September 07, 2016Guillermo Garcia-Manero, MD: A Unified Approach to Lower Risk MDS: Standard and Emerging TherapiesWebcast: 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes22 minPlay
September 07, 2016Bart Scott, MD: A Unified Approach to Higher Risk MDS: Standard and Emerging TherapiesWebcast: 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes23 minPlay
September 07, 2016Guillermo Garcia-Manero, MD: How to Approach HMA Failure?Webcast: 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes23 minPlay